Vanderbilt Kennedy Center
-
November 10, 2022
Kennedy Center seeks participants for disabilities research learning sessions
In January, a series of online learning sessions hosted by Vanderbilt Kennedy Center will bring together stakeholders who wish to see research advance toward understanding and solving the health problems that tend to affect adults with IDD. -
September 8, 2022
Juárez named director of behavior analysis
Pablo Juárez, MEd, BCBA, LBA, has been named director of behavior analysis within the Vanderbilt Kennedy Center and the Division of Developmental Medicine at Vanderbilt University Medical Center. -
April 28, 2022
Rajaraman named TRIAD director of behavioral analysis
Adithyan Rajaraman, PhD, BCBA-D, LBA, has been named director of the Vanderbilt Kennedy Center Treatment & Research Institute for Autism Spectrum Disorders. -
December 28, 2021
Vanderbilt Kennedy Center produces videos to build vaccine confidence in disability community
-
December 6, 2021
Potential Rett syndrome drug shows promising results in phase 3 trial
A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety. -
December 2, 2021
VKC data shows increase in autism spectrum disorder prevalence, provides new data on 4-year-olds
Vanderbilt Kennedy Center (VKC) researchers are seeing an increase in the number of children in Tennessee with autism spectrum disorder (ASD). -
October 28, 2021
SENSE Theatre production of “The Adult School” brings together diverse cast
The goal of the SENSE Theatre program is to improve the social and emotional functioning of individuals with autism spectrum disorder through using behavioral and theater techniques.